,i  #aad? ,,congress  #b;d ,session  ,h4
 ,r4 #dihb  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,april #ah1 #bjaf ,mr4
 ,fo/] 7= himself & ,mr4 ,pallone7      
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to direct ! ,comptroll] ,g5]al 
( ! ,unit$ ,/ates to evaluate & report  
on ! 9-pati5t & outpati5t treatm5t      
capacity1 availability1 & ne$s ( !      
,unit$ ,/ates4  #a4 ,%ort title ,?is    
,act may be cit$ z ! ,exam9+ ,opioid    
,treatm5t ,infra/ructure ,act ( #bjaf4  
#b4 ,/udy on treatm5t infra/ructure ,n  
lat] ?an #bd mon?s aft] ! date (        
enactm5t ( ?is ,act1 ! ,comptroll]      
,g5]al ( ! ,unit$ ,/ates %all initiate  
an evaluation1 & submit to ,congress a  
report1 ( ! 9-pati5t & outpati5t        
treatm5t capacity1 availability1 & ne$s 
( ! ,unit$ ,/ates1 :i* %all include1 to 
! ext5t data is available--  7#a7 !     
capacity ( acute resid5tial or inpati5t 
detoxification programs2  7#b7 !        
capacity ( inpati5t cl9ical /abilization

 programs1 transitional resid5tial      
support s]vices1 & resid5tial           
rehabilitation programs2  7#c7 !        
capacity ( demographic specific         
resid5tial or inpati5t treatm5t         
programs1 su* z ^? design$ = pregnant   
wom5 or adolesc5ts2  7#d7 geographical  
diff]5ces ( ! availability ( resid5tial 
& outpati5t treatm5t & recov]y options =
 sub/ance use disord]s across ! cont9uum
 ( c>e2  7#e7 ! availability (          
resid5tial & outpati5t treatm5t programs
 t (f] treatm5t options bas$ on reliable
 sci5tific evid5ce ( efficacy = !       
treatm5t ( sub/ance use disord]s1       
includ+ ! use ( ,food & ,drug           
,adm9i/ration-approv$ m$ic9es &         
evid5ce-bas$ nonph>macological !rapies2 
7#f7 ! numb] ( pati5ts 9 resid5tial &   
specialty outpati5t treatm5t s]vices =  
sub/ance use disord]s2 &  7#g7 an       
assessm5t ( ! ne$ = resid5tial &        
outpati5t treatm5t = sub/ance use       
disord]s across ! cont9uum ( c>e4